Excellent. So even if nothing more is signed in the next 3 weeks we will have a record 3rd quarter in terms of clinical trials contract wins. I think 4Q could also be pretty special as we should start to see some flow from the ERT partnership and there is a monster Lilly Phase III contract lurking out there somewhere.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
-0.065(3.60%) |
Mkt cap ! $298.8M | |||
| Open | High | Low | Value | Volume |
| $1.81 | $1.81 | $1.69 | $138.8K | 78.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1633 | $1.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 600 | 1 |
View Market Depth
| Last trade - 15.52pm 30/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |